“…The diversity and lack of specificity of muscle pathology in IMNM is increasingly recognized and reported, and these cases further highlight the importance of interpreting the muscle biopsy with knowledge of the clinical context. 4 In addition, anti-HMGCR and anti-SRP antibodies have very low false positive and false negative rates, depending on the type of assay, and therefore the antibodies should also be interpreted in the appropriate clinical context. 5 In summary, we steadfastly agree with the authors on the importance of not missing the diagnosis of IMNM, due to its potential treatability.…”